- Home
- TZOO vs STRO Comparison
TZOO vs STRO Comparison
Compare TZOO & STRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TZOO
- STRO
- Stock Information
- Founded
- TZOO 1998
- STRO 2003
- Country
- TZOO United States
- STRO United States
- Employees
- TZOO N/A
- STRO N/A
- Industry
- TZOO Advertising
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- TZOO Consumer Discretionary
- STRO Health Care
- Exchange
- TZOO Nasdaq
- STRO Nasdaq
- Market Cap
- TZOO 110.9M
- STRO 96.6M
- IPO Year
- TZOO 2002
- STRO 2018
- Fundamental
- Price
- TZOO $8.00
- STRO $1.06
- Analyst Decision
- TZOO Strong Buy
- STRO Hold
- Analyst Count
- TZOO 3
- STRO 7
- Target Price
- TZOO $18.67
- STRO $1.97
- AVG Volume (30 Days)
- TZOO 156.6K
- STRO 1.6M
- Earning Date
- TZOO 10-28-2025
- STRO 11-10-2025
- Dividend Yield
- TZOO N/A
- STRO N/A
- EPS Growth
- TZOO N/A
- STRO N/A
- EPS
- TZOO 0.66
- STRO N/A
- Revenue
- TZOO $89,923,000.00
- STRO $104,473,000.00
- Revenue This Year
- TZOO $14.48
- STRO $65.48
- Revenue Next Year
- TZOO $16.32
- STRO N/A
- P/E Ratio
- TZOO $12.26
- STRO N/A
- Revenue Growth
- TZOO 6.58
- STRO N/A
- 52 Week Low
- TZOO $7.76
- STRO $0.52
- 52 Week High
- TZOO $24.85
- STRO $4.60
- Technical
- Relative Strength Index (RSI)
- TZOO 22.89
- STRO 54.51
- Support Level
- TZOO $7.76
- STRO $1.03
- Resistance Level
- TZOO $10.42
- STRO $1.18
- Average True Range (ATR)
- TZOO 0.50
- STRO 0.11
- MACD
- TZOO -0.23
- STRO 0.01
- Stochastic Oscillator
- TZOO 8.25
- STRO 49.94
About TZOO Travelzoo
Travelzoo acts as a publisher of travel and entertainment offers. It operates in four segments. Travelzoo North America segment, which is the key revenue driver, consists of operations in Canada and the U.S.; Travelzoo Europe segment consists of operations in France, Germany, Spain, and the U.K.; Jack's Flight Club segment consists of subscription revenue from premium members to access and receive flight deals from Jack's Flight Club via email or via Android or Apple mobile applications; and New Initiatives consists of Travelzoo's licensing activities in Asia Pacific territories. It derives its revenue through advertising fees including listing fees paid by travel, entertainment, and local businesses to advertise their offers on the company's media properties.
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.